Author: | Scardino, P. |
Article Title: | Update: NCCN prostate cancer clinical practice guidelines |
Abstract: | Prostate cancer is the most common cancer in American men. This discussion focuses on recent updates to the NCCN guidelines, including new therapies and directions for future research. © Journal of the National Comprehensive Cancer Network. |
Keywords: | cancer chemotherapy; aged; middle aged; cancer surgery; prednisone; clinical trial; cancer recurrence; placebo; cancer growth; cancer risk; united states; conference paper; chemotherapy; cancer staging; antineoplastic agent; cancer grading; clinical practice; prostate specific antigen; cancer prevention; chemoprophylaxis; antineoplastic agents, phytogenic; mass screening; nccn clinical practice guidelines; practice guideline; cancer research; risk assessment; docetaxel; prostate cancer; prostate-specific antigen; prostatic neoplasms; prostatectomy; prostate tumor; prostate biopsy; mitoxantrone; finasteride; medical society; taxoids; hormonal therapy; taxoid; digital rectal examination; practice guidelines; estramustine |
Journal Title: | Journal of the National Comprehensive Cancer Network |
Volume: | 3 |
Issue: | Suppl. 1 |
ISSN: | 1540-1405 |
Publisher: | Harborside Press |
Date Published: | 2005-11-01 |
Start Page: | S |
End Page: | 29 |
Language: | English |
PUBMED: | 16280109 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | --- - "Cited By (since 1996): 55" - "Export Date: 24 October 2012" - "Source: Scopus" |